Skip to Main Content

Clinical Studies and Protocols

Site Map Investigators Log-in
WFR-0883-Genetics of Developmental Face Blindness

 Return to List of Clinical Studies
 Return to List of Protocols for Neurologic and Psychiatric Disorders
The Genetics of Developmental Face Blindness, Prosopagnosia – a Clinical Pilot Project

Principal Investigator:


Contact Information:
Recruitment Specialist
1230 York Ave
New York, NY 10065
Telephone: 1800RUCARES
Enrollment Status:
Open to Enrollment

Brief Summary of Protocol:
The reason for doing this research is to better understand what causes face blindness. Face blindness is a disorder in which a person experiences difficulty recognizing faces. Face blindness affects 2.5% of the worldwide population. In this study, we want to study the genes (genetic material inherited from your parents) of people with face blindness to see if there is a mutation (alteration) in those genes. This may help determine if a genetic mutation causes face blindness. By looking at the performance of an individual with face blindness on certain behavioral tests and also looking at their genes, we may be able to determine if there is a relationship between genes and how faces are perceived. If the genes that cause it are found, treatments may be developed to help people who suffer from the disorder.

Detailed Description of Protocol:

What specifically makes a person eligible for the study?
You may be eligible to enter this study:

1) Normal vision in both eyes 2) Must have access to internet 3) At least one living family member who has Prosopagnosia 4) Fluent in English 5) No history of stroke, CVA, or cognitive impairment 6) No history of psychiatric disorder currently requiring medication 7) No history of brain surgery or TBI 8) No self-report history of colorblindness 9) No history of any brain tumor 10) No history of current seizure disorder



Children permitted to participate:

Potential Benefits.....
There is no potential benefit to participant

Compensation is provided